Aurisco Pharmaceutical Co.,Ltd. (605116.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.05B |
| Enterprise Value | 10.29B |
| P/E Ratio | 21.15 |
| PEG Ratio | -6.98 |
| Price/Sales Ratio | 4.89 |
| Price/Book Ratio | 2.98 |
| Enterprise/Revenue | 5.06 |
| Enterprise/EBITDA | 14.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.28 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 1.7B |
| Revenue/Share | 4.22 |
| Gross Profit | 1.01B |
| EBITDA | 678.98M |
| Net Income | 449.21M |
| Diluted EPS | 1.1 |
Balance Sheet
| Total Cash | 917.17M |
| Total Cash/Share | 2.3 |
| Total Debt | 969.5M |
| Total Debt/Equity | 0.36 |
| Current Ratio | 4.22 |
| Book Value Per Share | 6.8 |
Price History
| 52-Week Change | -6.45 |
| 52-Week High | 35.58 |
| 52-Week Low | 18.09 |
| Moving Average 50 Days | 20.39 |
| Moving Average 200 Days | 24.08 |
Statistics
| Average Volume | 4.56M |
| Shares Outstanding | 406.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.34 |
| Trailing Annual Dividend Yield | 1.67 |
| Payout Ratio | 0.31 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
